Pharma IQ | 11/27/2014
64% of biomanufacturing professionals said that reducing cross-contamination issues is driving them to invest in disposable solutions over the coming 12 months according to Pharma IQ’s Disposable Solutions for Biomanufacturing 2014 Survey. Another big factor on the current focus on extractables and leachables is the new Technical Report 66 produced by the Parenteral Drug Association (PDA) on the Application of Single-Use Systems in Pharmaceutical Manufacturing it aims to “provide t...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More